BMO Capital downgrades Omega Healthcare (OHI) to a Hold

BMO Capital analyst Juan C. Sanabria downgraded Omega Healthcare to a Hold today and set a price target of $45.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

C. Sanabria covers the Real Estate sector, focusing on stocks such as Healthpeak Properties, National Health Investors, and Omega Healthcare. According to TipRanks, C. Sanabria has an average return of 0.9% and a 46.49% success rate on recommended stocks.

Currently, the analyst consensus on Omega Healthcare is a Moderate Buy with an average price target of $46.56.

Based on Omega Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $311.59 million and a net profit of $179.72 million. In comparison, last year the company earned a revenue of $276.03 million and had a net profit of $111.76 million

Based on the recent corporate insider activity of 20 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of OHI in relation to earlier this year. Most recently, in November 2025, Taylor Pickett, the CEO of OHI bought 20,000.00 shares for a total of $862,800.00.